Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia

被引:13
|
作者
Podgornik, Helena [1 ]
Pretnar, Jozef [1 ]
Skopec, Barbara [1 ]
Andoljsek, Dusan [1 ]
Cernelc, Peter [1 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Haematol, Ljubljana 1000, Slovenia
关键词
Atypical CLL; IGH translocation; t(2; 14); t(14; 19); t(18; 22); CHROMOSOMAL TRANSLOCATIONS; T(14/19)(Q32; Q13); PROGNOSIS; SURVIVAL; FEATURES; T(14/18);
D O I
10.1179/1607845413Y.0000000078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The most frequent chromosomal aberrations with the well established prognostic meaning in chronic lymphocytic leukemia (CLL) are + 12, del(11q), del(13q), and del(17p). Less common translocations lead to deregulation of genes primarily due to juxtaposition with IGH gene. We present a case of CLL patient with atypical morphology and an aggressive course of disease. In spite of aggressive treatment including allogeneic hematopoietic stem cell transplantation disease progressed into a rare cutaneous Richter's syndrome. Trisomy 12 was found as a sole chromosomal change at initial cytogenetic analysis of lymphoma cells. At progression, besides trisomy 12 three concomitant balanced translocations t(2; 14)(p13; q32), t(14; 19)(q32; q13), and t(18; 22)(q21; q11) were found. The same karyotype was confirmed in cells aspirated from skin infiltrates at Richter transformation. Atypical cytological features, trisomy 12, and a progressive course of disease observed in our case are typical for CLL with each of particular Ig translocations that were concomitantly found in CLL for the first time. Similar to "double hit" lymphoma concurrent rearrangements may be relevant also in CLL.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 50 条
  • [31] BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-Cell malignancies: A molecular and cytogenetic study
    McKeithan, TW
    Takimoto, GS
    Ohno, H
    Bjorling, VS
    Morgan, R
    Hecht, BK
    Dube, I
    Sandberg, AA
    Rowley, JD
    GENES CHROMOSOMES & CANCER, 1997, 20 (01): : 64 - 72
  • [32] Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements
    Ikoma, Haruka
    Miyaoka, Masashi
    Hiraiwa, Shinichiro
    Kikuti, Yara Yukie
    Shiraiwa, Sawako
    Hara, Ryujiro
    Kojima, Minoru
    Ohmachi, Ken
    Ando, Kiyoshi
    Carreras, Joaquim
    Nakamura, Naoya
    PATHOLOGY INTERNATIONAL, 2022, 72 (06) : 321 - 331
  • [33] Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
    Liu, Lin
    Mo, Wenbin
    Chen, Miao
    Qu, Yi
    Wang, Pingping
    Liang, Ying
    Yan, Xiaojing
    BMC CANCER, 2024, 24 (01)
  • [34] Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia
    Deambrogi, Clara
    De Paoli, Lorenzo
    Fangazio, Marco
    Cresta, Stefania
    Rasi, Silvia
    Spina, Valeria
    Gattei, Valter
    Gaidano, Gianluca
    Rossi, Davide
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (07) : 541 - 544
  • [35] Prognostic assessment of BCL2 C938A polymorphism in chronic lymphocytic leukemia (CLL)
    Rossi, Davide
    Rasi, Silvia
    Cerri, Michaela
    Deambrogi, Clara
    Cresta, Stefania
    Capello, Daniela
    Gaidano, Gianluca
    BLOOD, 2007, 110 (11) : 617A - 617A
  • [36] An illustrative case of t(14;19)/BCL3 rearrangement as a karyotypic evolution of chronic lymphocytic leukemia
    So Youn Shin
    Chan-Jeoung Park
    Kyoo Hyung Lee
    Jooryung Huh
    Hyun-Sook Chi
    Eul-Ju Seo
    Annals of Hematology, 2013, 92 : 1717 - 1719
  • [37] Pre-Clinical Study on the Dual BCL2/BCL-XL Inhibitor AZD0466 for the Treatment of Chronic Lymphocytic Leukemia
    Jebaraj, Billy
    Dheenadayalan, Rashmi Priyadharshini
    Mueller, Annika
    Qi, Jialei
    Tausch, Eugen
    Schneider, Christof
    Steinbrecher, Daniela
    Mertens, Daniel
    Seyfried, Felix
    Meyer, Lueder Hinrich
    Lechel, Andre
    Eichhorst, Barbara F.
    Andersen, Courtney L.
    Fabbri, Giulia
    Stilgenbauer, Stephan
    BLOOD, 2023, 142
  • [38] An illustrative case of t(14;19)/BCL3 rearrangement as a karyotypic evolution of chronic lymphocytic leukemia
    Shin, So Youn
    Park, Chan-Jeoung
    Lee, Kyoo Hyung
    Huh, Jooryung
    Chi, Hyun-Sook
    Seo, Eul-Ju
    ANNALS OF HEMATOLOGY, 2013, 92 (12) : 1717 - 1719
  • [39] BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia
    Perini, Guilherme Fleury
    Pellegrino Feres, Carolina Cristina
    Cardoso Teixeira, Larissa Lane
    Hamerschlak, Nelson
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (08)
  • [40] BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia
    Guilherme Fleury Perini
    Carolina Cristina Pellegrino Feres
    Larissa Lane Cardoso Teixeira
    Nelson Hamerschlak
    Current Treatment Options in Oncology, 2021, 22